Page last updated: 2024-08-26

bosentan anhydrous and Non-alcoholic Fatty Liver Disease

bosentan anhydrous has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fu, S; Li, Z; Ma, X; Sun, Z; Wang, A; Wang, Y; Zhang, D1

Other Studies

1 other study(ies) available for bosentan anhydrous and Non-alcoholic Fatty Liver Disease

ArticleYear
Heart failure with preserved ejection fraction and non-alcoholic fatty liver disease: new insights from bioinformatics.
    ESC heart failure, 2023, Volume: 10, Issue:1

    Topics: Bosentan; Computational Biology; Heart Failure; Humans; Non-alcoholic Fatty Liver Disease; Stroke Volume

2023